Today’s issue of WorkCompRecap features Coventry’s release of the fourth and final portion of its 2016 First Script Drug Trends Report Series, which has continued to present traditional, managed, and unmanaged views, but is now offered in a great new format with more concise pieces that allow for easier examination of trends and recommendations for each section and view.
Part 4 of the series focuses on specialty medications and closed formularies. Specialty drugs, which are typically used to treat patients with complex, chronic conditions, have become widely discussed due to their exorbitant per-prescription costs, and while they represented only 1.1% of drug utilization, they account for nearly 5% of prescription drug costs. In the managed population, blood clotting and HIV/AIDS conditions were responsible for 74% of 2016’s utilization increase in 2016, while the 7.9% rise in specialty drug costs would have been greater if not for decreases in hepatitis drug usage.
Find out more (including a link to the free report!) by clicking here!